CORC

在结果中检索

CORC

浏览/检索结果: 共86条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Design and expected performances of the large acceptance calorimeter for the HERD space mission 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Pacini, Lorenzo;  Adriani, Oscar;  Bai, Yong-Lin;  Bao, Tian-Wei;  Berti, Eugenio
收藏  |  浏览/下载：33/0  |  提交时间：2022/12/30
Achievement of 100-kW Beam Operation in CSNS/RCS 会议论文
Brazil, 2021
作者:  S.Y. Xu;  Y.W. An;  J. Chen;  L. Huang;  M.Y. Huang
收藏  |  浏览/下载：2/0  |  提交时间：2022/01/18
Synchronization for three chaotic systems with different structures and its application in secure communication 会议论文
Chongqing, China, October 11, 2019 - October 13, 2019
作者:  Peng, Peng;  Li, Suoping;  An, Xinlei;  Wang, Fan;  Dou, Zufang
收藏  |  浏览/下载：3/0  |  提交时间：2020/11/15
The Synchronization between BPMs and Corrector Power Supplies in AC Mode of RCS of CSNS 会议论文
Australia, 2019
作者:  M.T. Li;  Y.W. An;  S. Wang;  S.Y. Xu
收藏  |  浏览/下载：20/0  |  提交时间：2019/08/06
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：45/0  |  提交时间：2019/12/05
A design method for absorption of low-frequency noise using acoustic metamaterials 会议论文
2019 2nd International Conference on Advanced Materials, Intelligent Manufacturing and Automation, AMIMA 2019, Zhuhai, China, 2019-05-17
作者:  Xu, Xi'An;  Wang, Xiaoming;  Mei, Yulin
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/02
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：35/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace